Skip to main content

Site notifications

Maxx Pharma Pty Ltd

Regulatory activities for this sponsor.

Sponsor content

5 result(s) found, displaying 1 to 5
  • TGA Decision: Vaxelis (DTPa5-HB-IPV-Hib) is approved as a vaccine for diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis and Hib.
  • Australian prescription medicine decision summary
  • TGA decision: Ongentys (opicapone) is approved as adjunctive therapy in adult patients with Parkinson's disease.

Help us improve this page